MITF-M-dependent gene expression

Stable Identifier
R-HSA-9856651
Type
Pathway
Species
Homo sapiens
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this pathway in the Pathway Browser
MITF-M is a transcriptional regulator that is critical for the establishment of melanocyte fate during embryogenesis. Key targets include the enzymes responsible for the synthesis of the pigment compounds eumelanin and pheomelanin, as well as a number of structural components of the melanosome. In addition to regulating expression of genes involved in pigmentation, MITF has also been shown to play a role in the expression of genes involved in more diverse biological processes, including proliferation, survival, lysosome biogenesis, autophagy, metabolism, DNA damage, senescence and invasion (reviewed in Goding and Arnheiter, 2019; Mort et al, 2015; Zon and White, 2008, Cheli et al, 2010). Although widely characterized as a transcriptional activator, MITF-M has also be shown to act as a transcriptional repressor, negatively regulating the expression of genes involved in extracellular matrix organization, focal adhesion and epithelial-to-mesenchymal transition (Dilshat et al, 2021; reviewed in Rambow et al, 2019).
MITF is a basic helix loop helix leucine zipper (BHLH-ZIP)-containing protein and binds DNA as a dimer - either as a homodimer or as a heterodimer with the related transcription factors TFEB, TFE3, and TFEC. TFEB and TFE3 are both widely expressed, but TFEC displays more restricted expression. In this pathway, for simplicity, MITF is shown binding DNA exclusively as a homodimer (reviewed in Goding and Arnheiter, 2019).
MITF and related BHLH protein family members bind to an E-box-like element with sequence CANNTG. Specificity of binding is determined both by the flanking nucleotides and by the identity of the two internal nucleotides of the E-box element. MITF binds preferentially to sequences CATGTG or CACGTG, and binds with less affinity to the CAGCTG sequences preferred by other BHLH proteins such as AP4 (Lowing et al, 1992; Bentley et al, 1994; Yavuzer and Goding, 1994). High-affinity MITF-binding sites also show an enrichment for flanking 5'T and 3'A, further distinguishing these sites from those preferentially bound by transcription factors such as MYC and MAX (Aksan and Goding, 1998; Fisher et al, 1993; Solomon et al, 1993; Hejna et al, 2018). Variants of high-affinity MITF binding sites present in the promoters of pigmentation genes are called M-boxes, to distinguish them from related E-box sequences (reviewed in Goding and Arnheiter, 2019). Direct targets of MITF-M have been identified by ChIP-seq and CUT-and-RUN analysis in a number of primary and melanoma cell lines (Strub et al, 2011; Webster et al, 2014; Dilshat et al, 2021). In one of these studies, high-throughput ChIP-seq in the human melanoma cell line 501Mel identified MITF-binding at 5578 potential target genes, with 2771 showing promoter-proximal binding; only a subset of these genes were shown to be directly regulated by MITF, however (465; 240 down-regulated upon MITF knockdown, and 225 upregulated upon MITF overexpression) (Strub et al, 2001; reviewed in Goding and Arnheiter, 2019). MITF-bound genes included those involved in melanocyte biogenesis as well as DNA replication, repair and mitosis (Strub et al, 2011). Other studies have identified roles for MITF-M as a direct repressor of a number of genes implicated in estracellular matrix organization, cell adhesion, invasion and epithelial-to-mesenchymal transition (Laurette et al, 2015; Dilshat et al, 2021; reviewed Rambow et al, 2019).
Literature References
PubMed ID Title Journal Year
25670789 The melanocyte lineage in development and disease

Jackson, IJ, Patton, EE, Mort, RL

Development 2015
31575676 Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities

Rambow, F, Marine, JC, Goding, CR

Genes Dev 2019
1321344 Positive and negative elements regulate a melanocyte-specific promoter

Goding, CR, Lowings, P, Yavuzer, U

Mol Cell Biol 1992
8265351 Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers

Solomon, DL, Amati, B, Land, H

Nucleic Acids Res 1993
9819381 Targeting the microphthalmia basic helix-loop-helix-leucine zipper transcription factor to a subset of E-box elements in vitro and in vivo

Goding, CR, Aksan, I

Mol Cell Biol 1998
24443471 Enhancer-targeted genome editing selectively blocks innate resistance to oncokinase inhibition

Bussat, RT, Neela, PH, Barajas, B, Flockhart, RJ, Yan, KJ, Webster, DE, Kovalski, J, Khavari, PA, Zehnder, A

Genome Res 2014
21258399 Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma

Ye, T, Cormont, M, Keime, C, Kobi, D, Davidson, I, Le Gras, S, Giuliano, S, Bonet, C, Bertolotto, C, Ballotti, R, Strub, T

Oncogene 2011
8164694 Melanocyte-specific gene expression: role of repression and identification of a melanocyte-specific factor, MSF

Goding, CR, Yavuzer, U

Mol Cell Biol 1994
30548162 Local genomic features predict the distinct and overlapping binding patterns of the bHLH-Zip family oncoproteins MITF and MYC-MAX

Kawakami, A, Cheng, J, Moon, WM, Song, JS, Fisher, DE, Hejna, M

Pigment Cell Melanoma Res 2019
8262050 Transcription activation by Myc and Max: flanking sequences target activation to a subset of CACGTG motifs in vivo

Goding, CR, Gillespie, DA, Jayaraman, PS, Fisher, F, Clark, W, Crouch, DH

EMBO J 1993
18786412 Melanocytes in development, regeneration, and cancer

White, RM, Zon, LI

Cell Stem Cell 2008
31123060 MITF-the first 25 years

Arnheiter, H, Goding, CR

Genes Dev 2019
12730698 A new phospholipid phosphatase, PRG-1, is involved in axon growth and regenerative sprouting

Nitsch, R, Savaskan, NE, Kühn, H, Bräuer, AU, Ninnemann, O, Prehn, S

Nat. Neurosci. 2003
19995375 Fifteen-year quest for microphthalmia-associated transcription factor target genes

Bertolotto, C, Cheli, Y, Ohanna, M, Ballotti, R

Pigment Cell Melanoma Res 2010
33438577 MITF reprograms the extracellular matrix and focal adhesion in melanoma

Kenny, C, Steingrímsson, E, Ogmundsdottir, MH, Dilshat, R, Sigurbjornsdottir, S, Magnusdottir, E, Fock, V, Eichhoff, OM, Lasseur, RMJ, Einarsdottir, BO, Larue, L, Möller, K, Travnickova, J, Gerritsen, I, de Tayrac, M, Kirty, K, Cerny, P, Patton, EE, Levesque, M, Cheng, PF, Cornell, RA

Elife 2021
7969139 Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator

Eisen, T, Bentley, NJ, Goding, CR

Mol Cell Biol 1994
Participants
Participates
Orthologous Events
Authored
Reviewed
Created
Cite Us!